#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Familial haemophagocytic lymphohistiocytosis Pelizaeus-Merzbacher disease Glycogen storage disease type I Chondrodystrophy Crigler-Najjar syndrome Erdheim-Chester disease Oesophageal squamous cell carcinoma stage II Rheumatoid arthritis Acute lymphocytic leukaemia recurrent Thermal burn Hypersensitivity pneumonitis Spinal cord injury Focal segmental glomerulosclerosis Infertility male Chronic lymphocytic leukaemia More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy – Diagnostics Glomerulonephritis membranous – Diagnostics Anaplastic thyroid cancer – Life with Disease Gaucher’s disease type III – Trials in Disease Mucopolysaccharidosis – Diagnostics Nephroblastoma – Basic Information Haemophilia A with anti factor VIII – Diagnostics Chronic granulomatous disease Ewing’s sarcoma recurrent Mantle cell lymphoma refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Encorafenib Kd050 Arrhenatherum Elatius Bi 3720931 Cinnarizine Theophylline Corline Heparin Conjugate INSULIN DETEMIR ZUNIBERGENE ROCPARVOVEC 68Ga-Dpi-4452 Tolinapant Lactate Poloxamer 407 Azd5863 Tinlarebant Candesartan Azd8205 Prednisolone Acetate Calcium Fludarabine Phosphate Ph. Eur. Vitamin A Bp More therapies…

    Learn about Your Condition

    Hand fracture Biliary neoplasm Asplenia Electronic cigarette user Cholecystitis acute Cervix carcinoma Shock Lumbosacral radiculopathy Nasopharyngeal cancer Systemic infection Macular oedema Triple positive breast cancer Pancreatic carcinoma stage IV Pre-eclampsia Immune thrombocytopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Austria Belgium Czechia Denmark France Germany +9

  • Study to evaluate the effect of methylphenidate hydrochloride on the time to wake up in patients in a coma due to acute brain injury

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Coma
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    Austria Denmark France Germany

  • Study of asciminib, dexamethasone, blinatumomab, and vincristine sulfate in children and young adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Methotrexate
    • Asciminib Hydrochloride
    • Blinatumomab
    Czechia Denmark France Germany Italy The Netherlands +1

  • A study to evaluate the safety of MRM-3379 in men with Fragile X Syndrome

    Not yet recruiting

    2 1
    Spain

  • A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn7508
    Belgium Bulgaria Czechia France Germany Poland +2

  • A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    France
Previous Page
1 … 716 717 718 719 720 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!